StonvexLoading…
StonvexStonvexStonvexCore line items from INVX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $239.03M | $978.25M | $704.65M | $464.65M |
Operating Income | $-21.83M | $132.63M | $106.83M | $44.55M |
Net Income | $-16.67M | $83.30M | $69.33M | $30.10M |
EPS (Diluted) | $-0.24 | $1.20 | $1.00 | $0.43 |
Total Assets | $1.29B | $1.27B | $1.25B | $1.23B |
Total Liabilities | $256.77M | $210.61M | $214.96M | $231.53M |
Cash & Equivalents | $200.71M | $203.41M | $163.37M | $68.78M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 68.64M | 69.08M | 68.92M | 68.78M |